Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3133368
Max Phase: Preclinical
Molecular Formula: C53H65N13O13
Molecular Weight: 1092.18
Molecule Type: Unknown
Associated Items:
ID: ALA3133368
Max Phase: Preclinical
Molecular Formula: C53H65N13O13
Molecular Weight: 1092.18
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(C)=O)C/C=C/C[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC1=O
Standard InChI: InChI=1S/C53H65N13O13/c1-4-28(2)45-52(77)62-39(17-18-44(69)70)47(72)63-42(22-33-25-55-27-58-33)51(76)64-41(21-32-24-54-26-57-32)50(75)60-37(46(71)65-43(53(78)79)20-31-23-56-36-10-6-5-9-35(31)36)11-7-8-12-38(48(73)66-45)61-49(74)40(59-29(3)67)19-30-13-15-34(68)16-14-30/h5-10,13-16,23-28,37-43,45,56,68H,4,11-12,17-22H2,1-3H3,(H,54,57)(H,55,58)(H,59,67)(H,60,75)(H,61,74)(H,62,77)(H,63,72)(H,64,76)(H,65,71)(H,66,73)(H,69,70)(H,78,79)/b8-7+/t28-,37-,38-,39-,40-,41-,42-,43-,45-/m0/s1
Standard InChI Key: BRFCNXOPOLGUMO-GZBWWYMSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1092.18 | Molecular Weight (Monoisotopic): 1091.4825 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Meinander K, Weisell J, Pakkala M, Tadd AC, Hekim C, Kallionpaa R, Widell K, Stenman U, Koistinen H, Narvanen A, Vepsalainen J, Luthman K, Wallen EAA. (2013) Pseudopeptides with a centrally positioned alkene-based disulphide bridge mimetic stimulate kallikrein-related peptidase 3 activity, 4 (3): [10.1039/C3MD20292E] |
Source(1):